Abstracts

BRAIN VOLUMETRICS DIFFER BY FIEBIG STAGE IN ACUTE INFECTION

People with chronic HIV exhibit neuroimaging abnormalities compared to people without HIV (PWOH), including lower regional brain volumes. Whether volumetric differences exist during acute HIV (AH) is unknown. The present study examined brain volume by Fiebig stage in a large sample of people with AH (PWAH) enrolled in RV254/SEARCH 010, compared to demographically similar PWOH…

MACHINE LEARNING QUANTIFIES ACCELERATED WHITE MATTER AGING IN PERSONS WITH HIV

Older persons with HIV (PWH) undergo pathological changes to cerebral white matter, detectable on diffusion-weighted MRI. These changes can be quantified using the brain age gap (BAG), the difference between true age and neuroimaging-predicted ‘brain age.’ It is hypothesized that white matter aging, i.e. progressive accumulation of microstructural damage, is accelerated in PWH with detectable…

IMPACT OF INTEGRASE STRAND TRANSFER INHIBITORS ON COGNITION IN THE HAILO COHORT

Understanding the impact of antiretroviral therapy (ART) on neuropsychological (NP) outcomes, particularly cognition, in aging people with HIV (PWH) is important. Integrase Strand Transfer Inhibitors (INSTIs) have previously been associated with poorer cognitive outcomes. From ACTG’s observational aging cohort study A5322 (HAILO), we identified PWH who had 1) switched to an INSTI 2) had at…

HIV-1 Nef IMPAIRS MYELIN AND DISRUPTS GLIAL CELLS IN THE CENTRAL NERVOUS SYSTEM

HIV-associated neurocognitive disorder (HAND) pathogenesis has been linked to white matter damage, but the mechanisms underlying HIV-associated demyelination are unclear. We have previously shown that HIV-1 Nef is secreted from cells in extracellular vesicles (EVs) and impairs cholesterol efflux from macrophages via the cholesterol transporter ABCA1. Since oligodendrocytes require cholesterol for myelination, this study examined…

NLRP3 INFLAMMASOME SIGNALING PATHWAY IS UPREGULATED IN BRAINS OF PEOPLE WITH HIV-1

Human immunodeficiency virus type 1 (HIV-1) causes a chronic disease that may be associated with neuroinflammation. In the setting of neuroinflammation, people with HIV-1 (PWH) can develop cognitive impairment: with active brain viral replication, this reflects HIV encephalitis (HIVE); in the absence of replicating HIV, mechanisms underlying brain inflammation despite viral suppression on antiretroviral therapies…

H/L-FERRITINS AND TIM-1 ASSOCIATED WITH NEUROCOGNITIVE FUNCTION IN PEOPLE WITH HIV

HIV infection and inflammation alter iron homeostasis, which is essential for energy production and brain health. We previously reported that higher cerebrospinal fluid levels of the oligodendrocyte iron-delivery protein ferritin heavy-chain (Fth1) may protect against neurocognitive impairment (NCI) in people with HIV (PWH). Here, we hypothesized that higher serum Fth1 and ferritin light-chain (Ftl) levels,…

CSF EXOSOME A?42 AND TAU/A?42 RATIO ASSOCIATED WITH COGNITIVE DISORDERS IN OLDER PWH

HIV-associated neurocognitive disorders (HAND) remain prevalent despite viral suppression on current antiretroviral therapy (ART). Older people with HIV (PWH) are also at risk for amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD), but biomarkers to distinguish these disorders from HAND are unavailable. ?-amyloid (A?) and Tau are associated with cognitive decline in aMCI/AD, but…